MAPK and Src inhibitors showed synergistic induction of apoptosis and tumor inhibition in ovarian cancer mouse model. Treatment decreased spheroid formation and ALDH1 expression. The gene discussed is ALDH1A1; the disease is ovarian carcinoma.